Maze Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Maze Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Maze Therapeutics Inc.
Rating: 2.15283325
Author: Trendlyne DVM scores

about

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, i...

48.91 -1.48 (-2.94%)

New 52W High in past week

320.5K

XNAS Volume

XNAS 18 Mar, 2026 3:24 PM (EDT)

Board Meeting

The board meeting for Maze Therapeutics Inc is scheduled for today, for the purpose of Maze Therapeutics Inc Annual General Meeting for 2025 See details

Not Eligible

Expensive Valuation

8.8 / 100

Technically Bullish

77.3 / 100

1Yr Price target upside is 22%

11 analysts

Maze Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Maze Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, i...

New 52W High in past week

SWOT Analysis

Maze Therapeutics Inc Live Price Chart